• ქართული
  • English
  • Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

    Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday.

    Market Quotes by TradingView